Clinical Trials for Mural Oncology

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Mural Oncology

Clinical Trials (1)

NCT04592653
Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3)
PHASE1/PHASE2Active, not recruiting
78 participants
Started: Sep 30, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor6 locations